Nanotechnology Drug Delivery System Market is forecast to grow at high rate with growing CAGR of 9.2%

Global Nanotechnology Drug Delivery System Market is witnessing a high CAGR growth of 9.2% and is expected to reach USD 88.2 Bn by 2027.

The global nanotechnology drug delivery system market is growing significantly due to increasing investments in nanotechnology and advancements in nanoscale drug delivery system. Moreover, rising interest of pharmaceutical companies in the development of nanomedicines owing to the potential benefits offered by nanotechnology in medicinal research by formulating more potent drug delivery by decreasing side effects of the medications is leveraging the growth of nanotechnology drug delivery system industry.

Nanotechnology is booming in healthcare industry due to its advantages such as providing ability to deliver hydrophobic drug molecules at targeted site of action, reducing drug accumulation within tissues, and paves the way for transporting drug molecules across the barriers. In July 2021, researchers of Tel Aviv University developed a unique nanotechnology-based device that allowed the human body to produce electric currents on stimulation of organs. Researchers claimed that this innovative technology will benefit the human body in harvesting clean energy that is needed to operate implanted medical devices instead of batteries. Such inventions are gaining attention of manufacturing companies for the implementation of nanotechnology in drug delivery system which boost the growth of nanotechnology drug delivery system industry.

On the contrary, growing investments for the development of nanotechnology drug delivery system and inflated cost of clinical translation of nanomedicine is expected to hinder the growth of nanotechnology drug delivery system industry.

Covid-19 pandemic has positively impacted the growth of nanotechnology drug delivery system industry. This is due to its promising capacity of addressing many unmet needs to fight covid-19 crisis such as effective and safe diagnosis approach, diagnosis, and vaccination to prevent wide spread of coronavirus and mortality crisis. Many pharmaceutical and biopharmaceutical companies are focusing on the development of drugs and vaccines based on nanotechnology which is expected to uplift the growth of industry during pandemic.

Global Nanotechnology Drug Delivery System Market by Region Outlook (Revenue, USD Million, 2021-2027)

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Based on region, Asia-Pacific is expected to witness remarkable growth during the forecast period due to increasing number of key manufacturing units and rising number of chronic diseases. Moreover, rising demand for site-specific drug delivery system and ongoing research activities in the development nanotechnology in drug delivery and medical devices are expected to boost the growth of nanotechnology drug delivery industry.

 The Global Nanotechnology Drug Delivery System Market Segmentation:

Global Nanotechnology Drug Delivery System Market by Type Outlook (Revenue, USD Million, 2021-2027)

• Nano emulsion
• Nanoparticle
• Nanocrystal
• Liposomes
• Micelles

Global Nanotechnology Drug Delivery System Market by Application Type Outlook (Revenue, USD Million, 2021-2027)

• Oncology
• Cardiovascular
• Neurology
• Anti-inflammatory
• Anti-infective

Key Findings:

• Based on type, nanoparticle segment is expected to boost the growth of industry due to rising introduction of nanoparticle-based formulations in drug delivery system
• Based on application, cardiovascular segment anticipated to witness fastest market growth during forecast period owing to increasing prevalence of cardiovascular diseases and ongoing research on heart targeted nanocarrier based drug delivery
• Based on region, North America dominated in the nanotechnology drug delivery system market in 2020 and expected to maintain same dominance during forecast period

Company Profiles and Competitive Intelligence

The key players operating in the nanotechnology drug delivery system market are:

1. Taiwan Liposome Company
2. Nanobiotix
3. NanoCarrier Corporation ltd.
4. Tarveda Therapeutics
5.  Aquanova AG
6. AbbVie, Inc.
7. Amgen, Inc.
8. Celgene Corporation
9. Johnson & Johnson
10. Merck & Co., Inc.
11. Novartis International AG
12. Pfizer
13. Bayers
14. Starpharma Holdings Limited
15. Selecta Biosciences
16. Others
17. Nanocarrier Co. Ltd
18. Camarus AB
19. Cristal Therapeutics
20. Nanology LLC
21. Lena Nanoceutics Ltd

Recent News:

• In October 2021, Amgen announced the completion of acquisition with Teneobio,Inc The company has successfully gained outstanding equity of Teneobio in exchange of USD 900 Mn cash payment. This acquisition included proprietary multispecific antibody technologies that complemented Amgen’s antibody capabilities and BiTE® which would show significant efficiency for the development of new molecules that have treat to the Amgen’s core therapeutic areas.  
• In April 2020, Bioavanta-Bosti launched nanoparticle-based aerosol formulation named as Novochizol™ that can be used to deliver anti-covid-19 drug directly into lungs for acutely infected patients for sustained release in tissue or organ.